Ossianix Cracks Open The Blood-Brain Barrier

 
• By John Davis

By using the binding region of shark antibodies as a carrier to cross the blood-brain barrier, Ossianix reckons it has made significant progress against an issue that has held back the development of CNS-active neurological therapies.

Breaking through wall

More from R&D

More from Scrip